Latest Accounting News

Yowie Group has arranged a $1 million short-term funding facility from parent Keybridge Capital to manage cash flow while investigating former directors' use of funds and intra-group loans.

Magnetic Resources NL has reported a significant 22% increase in gold resources at its Lady Julie Gold Project, now containing over 2.14 million ounces, while securing a key Native Title Agreement that clears the path for mining leases and development.

Mesoblast has reported a strong commercial debut for Ryoncil, the first FDA-approved mesenchymal stromal cell therapy for pediatric steroid-refractory acute graft-versus-host disease, generating US$13.2 million in gross revenue in its initial quarter. The company is advancing regulatory and clinical milestones while expanding insurance coverage across the US.

Metals Australia Ltd has significantly expanded its Lac Carheil graphite project resource with a 595% increase in graphitic carbon intercepts, setting the stage for an updated Mineral Resource Estimate and advanced mine planning.

Navigator Global Investments (NGI) reported a 7% rise in total firm-level assets under management (AUM) to USD 86 billion in the June 2025 quarter, driven by strong performance from Lighthouse Partners and strategic private markets.

Santos Limited reported robust operational and financial results for Q2 2025, driven by solid production and cash flow, while its flagship Barossa LNG and Pikka projects advance on schedule. The company also navigates flood impacts and a notable acquisition proposal.

Visionflex Group delivered a standout Q4 FY25, posting $2.1 million in cash receipts and securing transformative contracts that underpin its expanding virtual healthcare footprint.

Gold Road Resources has agreed to a $3.40 per share acquisition by Gold Fields, combining fixed and variable cash components tied to Northern Star shares. Meanwhile, Gruyere mine production remains steady, with costs edging higher and strong cash flow underpinning the company’s financial position.

The ASX has published its latest list of entities suspended from trading for over three months, outlining key deadlines for report lodgement and trading resumption plans. Failure to meet these deadlines risks removal from the official list.

ImpediMed has doubled its US unit sales in Q4 FY25, achieving a record total contract value and securing an additional $5 million tranche under its growth capital facility.

Phoslock Environmental Technologies reported a $474,000 cashflow deficit in Q2 2025, with sales impacted by deferred European projects and ongoing US tariff uncertainties. Factory refurbishment delays push production restart to early 2026.

Legend Mining Limited reported a stable cash flow for the June 2025 quarter, ending with nearly AUD 11.8 million in cash and equivalents and an estimated 32.7 quarters of funding available.